What's Happening?
Allergan Aesthetics, a subsidiary of AbbVie, has announced the expansion of its SKINVIVE by JUVÉDERM® product to 35 additional markets, bringing the total to 57 global launches by 2025. SKINVIVE is a hydrating injectable designed to improve facial skin quality, offering long-lasting hydration and smoothness in a single treatment. This expansion is part of Allergan Aesthetics' strategic commitment to enhancing skin quality worldwide. The company is responding to a growing consumer demand for skin health-focused solutions, emphasizing natural-looking results over overt facial changes. The rollout is supported by research indicating that 94% of people wish to improve their facial skin quality, with deep hydration being a valued attribute across all age groups.
Why It's Important?
The expansion of SKINVIVE by JUVÉDERM® into new markets highlights a significant shift in consumer preferences towards skin health and natural aesthetics. This move is likely to impact the global skin quality market, valued at $5.2 billion, by offering innovative solutions that align with consumer desires for health, wellness, and natural beauty. Allergan Aesthetics' strategic focus on skin quality could influence industry standards and drive competition among aesthetic companies. Practitioners and patients stand to benefit from advanced treatment options that promise consistent and natural results, potentially increasing demand for such products and services.
What's Next?
Allergan Aesthetics plans to showcase its AA Signature™ approach at the Aesthetic Anti-Aging Medicine World Congress (AMWC) in Dubai, emphasizing a holistic approach to skin quality improvement. The company will continue to advance efforts in skin quality through global medical affairs initiatives, integrating aesthetic modalities for comprehensive skin enhancement. Healthcare professionals can expect further innovations and strategic product launches aimed at empowering practitioners to deliver optimal results for their patients.
Beyond the Headlines
The expansion of SKINVIVE by JUVÉDERM® may have deeper implications for the aesthetics industry, potentially setting new benchmarks for skin quality treatments. As consumer preferences evolve towards natural and health-focused aesthetics, companies may need to adapt their portfolios to meet these demands. This shift could also influence cultural perceptions of beauty, emphasizing health and vitality over traditional cosmetic enhancements.
